Description

Buy CJC-1295 No DAC Ipamorelin Blend 10mg | High Purity Research Peptide Europe

Welcome to euresearchpeptides.com — your trusted source for premium, laboratory-grade research peptides in Europe. Our CJC-1295 (No DAC) and Ipamorelin 10mg blend represents a sophisticated research tool for scientists investigating growth hormone axis signaling, endocrine regulation, and metabolic pathways in controlled laboratory settings. buy CJC-1295 no DAC Ipamorelin blend Europe

What Is the CJC-1295 (No DAC) and Ipamorelin Blend?

This research blend combines two complementary synthetic peptides: CJC-1295 (No DAC), a modified analog of growth hormone-releasing hormone (GHRH), and Ipamorelin, a selective ghrelin receptor agonist (growth hormone secretagogue). Each peptide targets distinct receptors in the growth hormone axis, allowing researchers to study synergistic pathway activation in vitro and in vivo. buy CJC-1295 no DAC Ipamorelin blend Europe

CJC-1295 (No DAC), also known as Modified GRF (1-29), consists of 29 amino acids and represents the bioactive fragment of endogenous GHRH. Unlike CJC-1295 with DAC (Drug Affinity Complex), this version does not contain the DAC moiety, resulting in a shorter half-life that preserves the physiologic pulsatile pattern of growth hormone secretion when studied in preclinical models. buy CJC-1295 no DAC Ipamorelin blend Europe

Ipamorelin is a pentapeptide that functions as a highly selective growth hormone secretagogue. It binds to the ghrelin receptor (GHSR-1a) in the pituitary and hypothalamus, triggering growth hormone release without significantly affecting ACTH, cortisol, or prolactin levels, making it a refined tool for GH axis research compared to earlier secretagogues.

This blend is strictly intended for laboratory research use only and is not for human consumption. Our product is manufactured using solid-phase peptide synthesis (SPPS) and purified via high-performance liquid chromatography (HPLC) with mass spectrometry confirmation.

How the CJC-1295 and Ipamorelin Blend Works: Mechanisms of Action

The synergistic research model of this blend operates through dual-receptor pathway activation:

CJC-1295 (No DAC) Mechanism: As a GHRH analog, CJC-1295 binds to GHRH receptors on somatotroph cells in the anterior pituitary. This binding activates the cAMP-dependent protein kinase A (PKA) signaling pathway, leading to growth hormone synthesis and secretion. The “No DAC” formulation allows researchers to study pulsatile GH dynamics rather than sustained elevation, more closely mimicking endogenous rhythms.

Ipamorelin Mechanism: Ipamorelin acts as a ghrelin receptor agonist (GHSR-1a). When bound to this G-protein coupled receptor, it triggers intracellular calcium mobilization and activation of the phospholipase C pathway, resulting in growth hormone release.

Synergistic Effect: When studied together, CJC-1295 amplifies the GH-releasing signal while Ipamorelin simultaneously suppresses somatostatin (the physiologic brake on GH secretion). This dual mechanism allows researchers to investigate enhanced GH pulse dynamics and pathway integration.

Research Applications

Performance Benefits for Research

Solubility Profile

This blend is soluble in aqueous solutions. For optimal experimental results:

• Primary solvent: Sterile water for injection or bacteriostatic water

• Alternative solvent: Dilute acetic acid (1%) for enhanced solubility

• Solvents to avoid: Pure organic solvents (acetonitrile, methanol, DMSO as primary solvent)

Reconstitution Protocol for 10mg Blend Vial:

• Add 2.0 mL bacteriostatic water to achieve approximately 5 mg/mL total concentration (2.5 mg/mL of each peptide)

• Gently swirl or roll until fully dissolved — do not shake

• Allow to sit for 1-2 minutes for complete dissolution

Stability and Storage Recommendations

Handling Protocols

For research use only. Proper handling ensures experimental integrity:

1. Allow vials to reach room temperature before opening to minimize condensation

2. Reconstitute by injecting diluent slowly down the vial wall; avoid foaming

3. Gently swirl or roll until fully dissolved — do not shake

4. Label with date, concentration, and lot number

5. Store reconstituted blend at 2-8°C and use within 30 days

6. Never freeze reconstituted solution after initial use

Research Dosing Guidelines for Laboratory Studies

The following are guidelines for research applications only:

Measurement Reference: At 5 mg/mL total concentration, 1 unit on a U-100 insulin syringe equals approximately 0.01 mL containing 50 mcg total (25 mcg of each peptide).

Quality Standards at EU Research Peptides

Our CJC-1295 (No DAC) and Ipamorelin blend is manufactured under strict quality control protocols:

• Synthesis: Solid-phase peptide synthesis (SPPS) with Fmoc chemistry

• Purification: HPLC purification to >99% purity

• Verification: Mass spectrometry (MS) confirmation of each component

• Quality Control: Each batch includes Certificate of Analysis (COA) with HPLC chromatogram and MS spectrum

• Facility: ISO-classified cleanroom manufacturing following cGMP guidelines

Why Researchers Choose EU Research Peptides

European-Based Operations: We are strategically located in the EU, ensuring fast, reliable shipping across Europe without customs delays.

Premium Quality: Every peptide batch undergoes rigorous third-party testing for purity, stability, and endotoxin levels.

Research Compliance: All products are labeled “For Research Use Only” and comply with EU chemical regulations.

Technical Support: Our team provides comprehensive documentation including COAs, MSDS, and reconstitution protocols.

Competitive Pricing: Bulk discounts available for research institutions and volume orders.

👉 Explore our complete catalog of research peptides at our official homepage.

Safety Considerations

CJC-1295 (No DAC) and Ipamorelin blend is intended for laboratory research purposes only. It is not for human consumption, therapeutic use, or veterinary applications. Researchers should:

• Follow institutional biosafety guidelines

• Use appropriate personal protective equipment (PPE)

• Handle all peptides with sterile technique

• Dispose of materials according to local regulations

• Refer to provided Material Safety Data Sheet (MSDS)

Frequently Asked Questions (FAQ)

What is CJC-1295 (No DAC)?

CJC-1295 (No DAC) is a synthetic 29-amino acid peptide analog of growth hormone-releasing hormone (GHRH). It is modified to resist enzymatic degradation while maintaining the bioactive properties of endogenous GHRH. Unlike CJC-1295 with DAC, this version lacks the Drug Affinity Complex, resulting in a shorter half-life that allows researchers to study pulsatile growth hormone secretion patterns rather than sustained elevation.

What is Ipamorelin?

Ipamorelin is a pentapeptide growth hormone secretagogue that acts as a selective agonist at the ghrelin receptor (GHSR-1a). It is known for its high selectivity, stimulating growth hormone release without significantly affecting cortisol, ACTH, or prolactin levels in research models.

Why combine CJC-1295 (No DAC) with Ipamorelin?

These two peptides target distinct receptors involved in growth hormone regulation. CJC-1295 amplifies the GHRH signal to the pituitary, while Ipamorelin suppresses somatostatin (the brake on GH secretion). Together, they allow researchers to study synergistic activation of the GH axis and enhanced pulsatile release dynamics.

What is the difference between CJC-1295 with DAC and without DAC?

CJC-1295 with DAC contains a Drug Affinity Complex that binds to albumin, extending its half-life to approximately 8 days and producing sustained GH elevation. CJC-1295 without DAC has a shorter half-life and produces pulsatile GH release that more closely mimics natural physiological patterns. This makes the No DAC version preferable for studies focused on natural GH pulse dynamics.

What purity level does EU Research Peptides offer for this blend?

Our CJC-1295 (No DAC) and Ipamorelin blend is tested at >99% purity by HPLC with mass spectrometry confirmation for each component. Each batch includes a Certificate of Analysis (COA) with detailed purity data.

How should I store this peptide blend?

Lyophilized blend should be stored at -20°C or below, protected from light and moisture. After reconstitution, refrigerate at 2-8°C and use within 30 days. Avoid repeated freeze-thaw cycles.

What is the recommended reconstitution protocol for the 10mg blend?

Add 2.0 mL of bacteriostatic water to the 10mg vial. This yields approximately 5 mg/mL total concentration (2.5 mg/mL of each peptide). Gently swirl or roll until fully dissolved. Do not shake.

What are the primary research applications for this blend?

This blend is studied in growth hormone axis research, metabolic studies, recovery and repair models, sleep and circadian research, aging and longevity investigations, and signal transduction studies involving GHRH-GHSR pathway integration.

Does this peptide blend suitable for cell culture research?

Yes, this blend can be used in cell culture studies investigating GH receptor signaling and somatotroph cell responses. Proper sterile technique and appropriate concentration ranges should be determined based on experimental design.

What documentation is provided with each order?

Each order includes a Certificate of Analysis (COA) with HPLC chromatogram and mass spectrometry data, material safety data sheet (MSDS), and reconstitution protocol.

How long does shipping take within Europe?

Standard shipping within the EU takes 3-5 business days. Express shipping options are available for urgent research needs.

Can I purchase this blend in larger quantities?

Yes, EU Research Peptides offers volume discounts for bulk orders. Contact our customer service team for customized quotes.

Is this peptide stable at room temperature during shipping?

The lyophilized blend is stable at ambient temperature during transit. Upon receipt, it should be immediately stored at -20°C to maintain long-term stability.